https://www.mlive.com/public-interest/2023/07/promising-alzheimers-therapy-could-soon-get-fda-approval.html
In clinical trials, bi-monthly injections of lecanemab slowed deterioration in patients with signs of dementia.
Create an account or login to join the discussion